BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farup PG, Modalsli B, Tholfsen JK. Long-term treatment with 300 mg ranitidine once daily after dilatation of peptic oesophageal strictures. Scand J Gastroenterol 1992;27:594-8. [PMID: 1641586 DOI: 10.3109/00365529209000124] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Spechler SJ. AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology. 1999;117:233-254. [PMID: 10381933 DOI: 10.1016/s0016-5085(99)70573-1] [Cited by in Crossref: 136] [Cited by in F6Publishing: 19] [Article Influence: 5.9] [Reference Citation Analysis]
2 Saeed ZA, Winchester CB, Ferro PS, Michaletz PA, Schwartz JT, Graham DY. Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus. Gastrointestinal Endoscopy 1995;41:189-95. [DOI: 10.1016/s0016-5107(95)70336-5] [Cited by in Crossref: 136] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
3 Silvis SE, Farahmand M, Johnson JA, Ansel HJ, Ho SB. A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis. Gastrointest Endosc 1996;43:216-21. [PMID: 8857137 DOI: 10.1016/s0016-5107(96)70319-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
4 Guda NM, Vakil N. Proton pump inhibitors and the time trends for esophageal dilation. Am J Gastroenterol 2004;99:797-800. [PMID: 15128339 DOI: 10.1111/j.1572-0241.2004.04169.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
5 Spechler SJ. Clinical Manifestations and Esophageal Complications of GERD. The American Journal of the Medical Sciences 2003;326:279-84. [DOI: 10.1097/00000441-200311000-00004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
6 Ramage JI Jr, Rumalla A, Baron TH, Pochron NL, Zinsmeister AR, Murray JA, Norton ID, Diehl N, Romero Y. A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol. 2005;100:2419-2425. [PMID: 16279894 DOI: 10.1111/j.1572-0241.2005.00331.x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 119] [Article Influence: 10.1] [Reference Citation Analysis]
7 Agnew SR, Pandya SP, Reynolds RPE, Preiksaitis HG. Predictors for frequent esophageal dilations of benign peptic strictures. Digest Dis Sci 1996;41:931-6. [DOI: 10.1007/bf02091533] [Cited by in Crossref: 22] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
8 Nayyar AK, Royston C, Bardhan KD. Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era. Dig Liver Dis 2003;35:143-50. [PMID: 12779067 DOI: 10.1016/s1590-8658(03)00021-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
9 Saeed ZA, Graham DY. Treatment of benign esophageal strictures: Where do we go from here? Digest Dis Sci 1994;39:2099-101. [DOI: 10.1007/bf02090356] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
10 Jon Spechler S. Esophageal complications of gastroesophageal reflux disease: Presentation, diagnosis, management, and outcomes. Clinical Cornerstone 2003;5:41-8. [DOI: 10.1016/s1098-3597(03)90098-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Smith PM, Kerr GD, Cockel R, Ross BA, Bate CM, Brown P, Dronfield MW, Green JR, Hislop WS, Theodossi A. A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group. Gastroenterology. 1994;107:1312-1318. [PMID: 7926495 DOI: 10.1016/0016-5085(94)90532-0] [Cited by in Crossref: 149] [Cited by in F6Publishing: 105] [Article Influence: 5.3] [Reference Citation Analysis]
12 Kamal A, Vaezi MF. Diagnosis and initial management of gastroesophageal complications. Best Pract Res Clin Gastroenterol 2010;24:799-820. [PMID: 21126695 DOI: 10.1016/j.bpg.2010.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
13 Sami SS, Haboubi HN, Ang Y, Boger P, Bhandari P, de Caestecker J, Griffiths H, Haidry R, Laasch HU, Patel P, Paterson S, Ragunath K, Watson P, Siersema PD, Attwood SE. UK guidelines on oesophageal dilatation in clinical practice. Gut. 2018;67:1000-1023. [PMID: 29478034 DOI: 10.1136/gutjnl-2017-315414] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
14 Eckardt VF, Kanzler G, Westermeier T. Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study. Gastrointest Endosc. 1997;45:349-353. [PMID: 9165313 DOI: 10.1016/s0016-5107(97)70143-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]